BP001645-CE12: Recombinant Human Endothelial Differentiation-Related Factor 1 (EDF1) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001645-PRO-494: Recombinant Human Endothelial Differentiation-Related Factor 1 (EDF1) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.PA005148-PA1337: FAF1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human, Mouse, Rat;
Isotype: Rabbit IgG.PA005007-PA1453: FGF9 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, IHC-P;
Reactivity: Human, Mouse, Rat;
Isotype: Rabbit IgG.PA001676-C10811: FOXK1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, ELISA;
Reactivity: Human, Mouse.PA001676-R12-2775: FOXK1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, ELISA;
Reactivity: Human, Mouse.BP000036-GD10: Recombinant Human FVII Protein
Source: HEK 293 cell derived.
Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.BP000036-GD11: Recombinant Human FVIIa Protein
Source: 293 cell derived.
The potency per mg of recombinant human FVIIa protein was tested and found to be 50,000 Units/mg.
Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE under reducing conditions.BP001902-PRO-331: Recombinant Human Coagulation Factor VIIa (FVIIa) Protein
Source: BHK cells-derived.
The potency per mg of recombinant human FVIIa protein was tested and found to be 50,000 Units/mg.
Purity: > 98.0% as determined by (a) Analysis by RP-HPLC; (b) Analysis by SDS-PAGE.BP000470-PRO-317: Human Coagulation Factor-VIII (FVIII) Protein
Source: Human Plasma-derived.
The potency per mg of Human Coagulation Factor-VIII was tested and found to be 150 Units/mg.